KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Hoofdauteurs: | , , , , , , , , , , , , , , , |
---|---|
Formaat: | Conference item |
Gepubliceerd in: |
2012
|
Samenvatting: |
---|